FDA
FDA Articles
Teva Pharmaceuticals shares made a solid gain on Monday morning after the company announced a critical approval by the FDA.
Published:
Last Updated:
STAAR Surgical shares made a handy gain on Friday after the firm announced a key approval by the FDA.
Published:
Last Updated:
Acorda Therapeutics shares dipped on Thursday after the company announced that the FDA would be delaying its Prescription Drug User Fee Act goal date for its review of the New Drug Application of...
Published:
Last Updated:
The FDA is cracking down on smoking, but not what is traditionally considered smoking. The agency is going after e-cigarette manufacturers, as teen smokers (vapers) have reached epidemic levels.
Published:
Last Updated:
Endocyte filed with the SEC for a secondary offering. In most cases where a company does this, we see the stock drop. However, in this case investors are cheering Endocyte and its secondary offering.
Published:
Last Updated:
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
Published:
Last Updated:
Endocyte shares made a solid gain early on Monday after the company announced an update from the FDA.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
Published:
Last Updated:
InsysTherapeutics shares made a handy gain early on Thursday after the company announced an update from the FDA.
Published:
Last Updated:
The topic of acceptable costs versus acceptable results is one that may never have a final conclusion in which everyone agrees.
Published:
Last Updated:
Akcea and Ionis were each crushed on Tuesday after the firms announced that they received a Complete Response Letter from the FDA.
Published:
Last Updated:
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
Published:
Last Updated:
Regeneron Pharmaceuticals is facing some difficulty after it received an update from the FDA on Eylea (aflibercept) Injection in patients with wet age-related macular degeneration.
Published:
Last Updated:
Mersana Therapeutics shares took a massive dive on Thursday morning after the company announced that the FDA put a partial hold on the firm’s early-stage cancer study.
Published:
Last Updated:
Voyager Therapeutics shares saw a handy gain on Tuesday after the company announced that it received some feedback from the FDA.
Published:
Last Updated: